As of 2025-09-15, the Relative Valuation of Immunovant Inc (IMVT) is (69.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.16 USD, the upside of Immunovant Inc based on Relative Valuation is -532.7%.
The range of the Relative Valuation is (68.51) - (68.72) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.3x - 26.8x | 24.5x |
| Forward P/E multiples | 26.7x - 32.3x | 30.0x |
| Fair Price | (68.51) - (68.72) | (69.92) |
| Upside | -524.0% - -525.2% | -532.7% |
| Date | P/E |
| 2025-09-08 | -6.38 |
| 2025-09-05 | -6.68 |
| 2025-09-04 | -6.28 |
| 2025-09-03 | -6.51 |
| 2025-09-02 | -5.87 |
| 2025-08-29 | -5.72 |
| 2025-08-28 | -5.78 |
| 2025-08-27 | -5.92 |
| 2025-08-26 | -5.88 |
| 2025-08-25 | -5.80 |
| 2025-08-22 | -5.94 |
| 2025-08-21 | -5.78 |
| 2025-08-20 | -5.78 |
| 2025-08-19 | -5.78 |
| 2025-08-18 | -5.95 |
| 2025-08-15 | -5.93 |
| 2025-08-14 | -5.92 |
| 2025-08-13 | -6.19 |
| 2025-08-12 | -5.93 |
| 2025-08-11 | -5.75 |
| 2025-08-08 | -6.02 |
| 2025-08-07 | -6.13 |
| 2025-08-06 | -6.22 |
| 2025-08-05 | -6.43 |
| 2025-08-04 | -6.27 |
| 2025-08-01 | -6.12 |
| 2025-07-31 | -6.27 |
| 2025-07-30 | -6.48 |
| 2025-07-29 | -6.49 |
| 2025-07-28 | -6.53 |
| 2025-07-25 | -6.61 |
| 2025-07-24 | -7.14 |
| 2025-07-23 | -7.17 |
| 2025-07-22 | -6.99 |
| 2025-07-21 | -6.90 |
| 2025-07-18 | -6.98 |
| 2025-07-17 | -7.12 |
| 2025-07-16 | -6.94 |
| 2025-07-15 | -6.82 |
| 2025-07-14 | -7.24 |
| 2025-07-11 | -7.07 |
| 2025-07-10 | -6.82 |
| 2025-07-09 | -6.74 |
| 2025-07-08 | -6.58 |
| 2025-07-07 | -6.40 |
| 2025-07-03 | -6.61 |
| 2025-07-02 | -6.55 |
| 2025-07-01 | -6.29 |
| 2025-06-30 | -6.24 |
| 2025-06-27 | -6.27 |